Ando Yuichi 安藤雄一

… Alternative Names

ANDO Yuichi 安藤雄一

Less

Researcher Number	10360083
Other IDs	https://orcid.org/0000-0001-9524-7409
External Links
Affiliation (Current)	2025: 名古屋大学, 医学部附属病院, 教授
Affiliation (based on the past Project Information) *help	2012 – 2023: 名古屋大学, 医学部附属病院, 教授 2016: 名古屋大学, 医学部, 教授 2008 – 2011: Nagoya University, 医学部附属病院, 准教授 2005 – 2006: 名古屋大学, 医学部附属病院, 助教授 2003 – 2004: 埼玉医科大学, 医学部, 講師
Review Section/Research Field	Principal Investigator Applied pharmacology / Basic Section 50020:Tumor diagnostics and therapeutics-related Except Principal Investigator Medical pharmacy / Basic Section 47060:Clinical pharmacy-related / Applied pharmacology / Basic Section 52010:General internal medicine-related / Basic Section 53010:Gastroenterology-related / Basic Section 47030:Pharmaceutical hygiene and biochemistry-related / General internal medicine(including psychosomatic medicine) / Medical systems / Orthopaedic surgery / Gastroenterology / Respiratory organ internal medicine
Keywords	Principal Investigator がん薬物療法 / 医薬品副作用 / 遺伝子多型 / がん関連繊維芽細胞 / 免疫チェックポイント阻害薬 / 腫瘍免疫応答 / がん関連線維芽細胞 / 細菌 / 薬物治療学 / 癌 … More / 臨床 / 薬剤反応性 / 発熱性好中球減少 / 副作用 / バクテリアルトランスロケーション / 分子標的治療薬 / サルコペニア / 網膜血管 / 眼底検査 / 血管新生阻害薬 / 眼底所見 / 薬物相互作用 / QT延長 / がん化学療法 / 抗癌剤化学療法 / 薬物代謝酵素 … More Except Principal Investigator がん薬物療法 / 化学療法 / 抗体医薬 / インフュージョンリアクション / 遺伝子多型 / 分子標的薬 / 胃癌 / 薬物相互作用 / リツキシマブ / がん化学療法 / 癌 / バイオマーカー / 高齢者 / 免疫チェックポイント阻害薬 / 直接作用型経口抗凝固薬 / DOAC / PT-INR / 経口抗凝固薬 / 生薬 / 漢方薬 / 遺伝的多型 / 血栓塞栓症 / フッ化ピリミジン系抗がん剤 / ワルファリン / 消化器癌 / RNA発現 / 胃がん / 食道がん / 食道癌 / 循環腫瘍DNA / DNAメチル化 / 副作用軽減 / サイトカイン放出症候群 / FcRn 遺伝的多型 / 副作用 / バイオ医薬品 / 職業性曝露 / 遊離形 / イリノテカン塩酸塩 / long-lasting inhibition / indole / 尿毒素 / 肝代謝型 / 投与設計 / PBPKモデル / 蛋白結合 / SN-38 / 薬物動態 / イリノテカン / 肝消失型抗がん薬 / 腎機能障害 / 血管新生阻害作用 / 抗凝固薬 / HLA遺伝子型 / 遺伝子解析 / 治験 / TGN1412 / 人種差 / 実験動物 / 脂肪組織 / サルコペニア / がん悪液質 / search / drug adverse reaction / data base / grid computing / individual medicine / polymorphism / anti-cancer drug / pharmacokinetics / 塩酸イリノテカン / 個別化治療 / パスウエイ解析 / CeLLML / SNP / データウエアハウス / シミュレーション / バーチャルフェーズI / テーラーメイド医療 / 抗がん剤 / がん / 探索 / 薬剤副作用 / データベース / グリッドコンピューティング / 個別化医療 / 抗癌剤 / 薬物動態解析 / 骨転移 / 細胞外マトリックス / 骨修飾薬 / ヒアルロン酸 / 破骨細胞 / 転移性骨腫瘍 / 消化器がん / 薬剤耐性 / 腹膜播種 / マクロファージ / モノクローナル抗体製剤 / monoclonal antibody / infusion reaction / Rituximab / 医薬品副作用 / 薬剤反応性 / オーダーメード医療 / 非閉塞性肺疾患癌 / 肺癌 / 非閉塞性肺疾患 / 上皮間葉系細胞転換 Less

Study on proper use of oral anticoagulants combined with 5-fluorouracil
- Principal Investigator
  
  中村克徳
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  University of the Ryukyus
Exploring biomarkers for immune checkpoint inhibitors in elderly patients with cancer
- Principal Investigator
  
  下方智也
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 52010:General internal medicine-related
- Research Institution
  Nagoya University
Exploratory analysis of DNA methylation as a novel biomarker in gastrointestinal cancer chemotherapy
- Principal Investigator
  
  Maeda Osamu
- Project Period (FY)
  2020 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Nagoya University
Mechanism of predicting the effects of immune checkpoint inhibitors based on the diversity of cancer-associated fibroblastsPrincipal Investigator
- Principal Investigator
  
  Ando Yuichi
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Nagoya University
Creating scientific evidence of medical staff exposure through cancer chemotherapy
- Principal Investigator
  
  Mitsuma Ayako
- Project Period (FY)
  2019 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 47030:Pharmaceutical hygiene and biochemistry-related
- Research Institution
  Nagoya University
Factors involved in the efficacy and safety of biopharmaceuticals
- Principal Investigator
  
  Nakamura Katsunori
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  University of the Ryukyus
Mechanism of diarrhea/enteritis caused by anticancer drugs and development of new treatmentPrincipal Investigator
- Principal Investigator
  
  Ando Yuichi
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Applied pharmacology
- Research Institution
  Nagoya University
Study of the infusion reaction by rituximab
- Principal Investigator
  
  Nakamura Katsunori
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  University of the Ryukyus
Screening and prevention of vascular events for cancer patients, and investigation of the mechanisms.
- Principal Investigator
  
  Mitsuma Ayako
- Project Period (FY)
  2016 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Applied pharmacology
- Research Institution
  Nagoya University
Elucidation of sarcopenia mechanism in the cancer cachexia
- Principal Investigator
  
  Shimokata Tomoya
- Project Period (FY)
  2015 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  General internal medicine(including psychosomatic medicine)
- Research Institution
  Nagoya University
Clinical significance of sarcopenia in cancer chemotherapyPrincipal Investigator
- Principal Investigator
  
  Ando Yuichi
- Project Period (FY)
  2014 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Applied pharmacology
- Research Institution
  Nagoya University
Genetic analysis of peritoneal dissemination of gastrointestinal cancer
- Principal Investigator
  
  Maeda Osamu
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Nagoya University
Establishment of bone metastasis treatment by regulating hyaluronan network and osteoclast
- Principal Investigator
  
  Urakawa Hiroshi
- Project Period (FY)
  2014 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Orthopaedic surgery
- Research Institution
  Nagoya University
Mechanisms of delayed elimination and decreased plasma protein binding of anticancer drugs which are mainly eliminated via the liver in cancer patients with severe renal failure
- Principal Investigator
  
  Fujita Ken-ichi
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Showa University
Investigation of the infusion reaction development coursed by molecular target medicine prescription
- Principal Investigator
  
  NAKAMURA Katsunori
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  University of the Ryukyus
  Nagoya City University
Ophthalmologic assessment of retinal vessels as a biomarker of the pharmacological response to antiangiogenic cancer chemotherapyPrincipal Investigator
- Principal Investigator
  
  ANDO YUICHI
- Project Period (FY)
  2011 – 2013
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Applied pharmacology
- Research Institution
  Nagoya University
Genetic backgrounds of peripheral neuropathy induced by chemotherapy
- Principal Investigator
  
  MITSUMA Ayako
- Project Period (FY)
  2010 – 2012
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Applied pharmacology
- Research Institution
  Nagoya University
Development of personalized medicine for cancer chemotherapy according to a variety of sensitivity and pharmacokinetics
- Principal Investigator
  
  HAMADA Akinobu
- Project Period (FY)
  2009 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Kumamoto University
Clinical and genetic factors of drug-induced QT interval prolongation in patients who receive cancer chemotherapyPrincipal Investigator
- Principal Investigator
  
  ANDO Yuichi
- Project Period (FY)
  2008 – 2010
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Applied pharmacology
- Research Institution
  Nagoya University
Identification of Epithelial-to-Mesenchymal Transition-Associated Genes as Therapeutic Targets for Lung Cancer
- Principal Investigator
  
  SATO Mitsuo
- Project Period (FY)
  2008 – 2010
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  National Institute for Longevity Sciences,NCGG
Development of clinical genome information systems for pharmacokinetics analysis
- Principal Investigator
  
  OYAMA Hiroshi
- Project Period (FY)
  2004 – 2006
- Research Category
  
  Grant-in-Aid for Scientific Research (A)
- Research Field
  
  Medical systems
- Research Institution
  The University of Tokyo
抗癌剤化学療法の個別化における薬物代謝酵素遺伝子多型診断の臨床応用Principal Investigator
- Principal Investigator
  
  安藤雄一
- Project Period (FY)
  2003 – 2004
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Applied pharmacology
- Research Institution
  Saitama Medical University

[Book] レジデントノート増刊　臨床現場の薬理学「がん薬物療法」2023
- Author(s)
  満間綾子、安藤雄一
- Total Pages
  6
- Publisher
  羊土社
- ISBN
  9784758127080
- Data Source
  KAKENHI-PROJECT-19K07083
[Book] 高齢者機能評価とレジメンでわかるがん薬物療法2022
- Author(s)
  安藤雄一他
- Total Pages
  297
- Publisher
  中外医学社
- ISBN
  9784498117204
- Data Source
  KAKENHI-PROJECT-19K07083
[Book] ハイリスク患者のがん薬物療法ハンドブック2017
- Author(s)
  満間綾子、安藤雄一
- Total Pages
  379
- Publisher
  （株）羊土社
- Data Source
  KAKENHI-PROJECT-16K08906
[Book] 抗悪性腫瘍薬コンサルトブック　改訂第2版2017
- Author(s)
  満間綾子、安藤雄一
- Total Pages
  430
- Publisher
  （株）南江堂
- Data Source
  KAKENHI-PROJECT-16K08906
[Book] がん診療のサポーティブケアガイド起こりうる症状・有害事象へのトータルマネジメント.安藤雄一2010
- Author(s)
  満間綾子,安藤雄一他
- Total Pages
  247
- Publisher
  文光堂
- Data Source
  KAKENHI-PROJECT-22590500
[Book] パクリタキセル.抗悪性腫瘍薬コンサルトブック.(南博信編)2010
- Author(s)
  満間綾子,安藤雄一
- Publisher
  南江堂
- Data Source
  KAKENHI-PROJECT-22590500
[Book] がん診療のサポーティブケアガイド起こりうる症状・有害事象へのトータルマネジメント2010
- Author(s)
  安藤雄一(編集)
- Total Pages
  256
- Publisher
  文光堂
- Data Source
  KAKENHI-PROJECT-20590537
[Book] EBMがん化学療法・分子標的治療法「塩酸イリノテカン投与時にUGTIAI遺伝子多型のチェックは必要か?」2010
- Author(s)
  満間綾子, 安藤雄一
- Publisher
  中外医学社ら
- Data Source
  KAKENHI-PROJECT-22590500
[Book] 抗悪性腫瘍薬コンサルトブック薬理学的特性に基づく治療「パクリタキセル」2010
- Author(s)
  満間綾子, 安藤雄一
- Publisher
  南江堂
- Data Source
  KAKENHI-PROJECT-22590500
[Book] がん診療のサポーティブケアガイド起こりうる症状・有害事象へのトータルマネジメント2010
- Author(s)
  安藤雄一(単独編集)
- Total Pages
  256
- Publisher
  文光堂
- Data Source
  KAKENHI-PROJECT-20590537
[Book] 外来がん化学療法マニュアル2009
- Author(s)
  安藤雄一(執筆および編集)
- Total Pages
  24
- Publisher
  文光堂
- Data Source
  KAKENHI-PROJECT-20590537
[Book] 抗悪性腫瘍薬.医系薬理学改訂2版(遠藤仁,橋本敬太郎,後藤勝年,金井好克編)2005
- Author(s)
  安藤雄一, 佐々木康綱
- Publisher
  中外医学社
- Data Source
  KAKENHI-PROJECT-16200038
[Journal Article] Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockade2022
- Author(s)
  Miyai Yuki、Sugiyama Daisuke、Hase Tetsunari、Asai Naoya、Taki Tetsuro、Nishida Kazuki、Fukui Takayuki、Chen-Yoshikawa Toyofumi Fengshi、Kobayashi Hiroki、Mii Shinji、Shiraki Yukihiro、Hasegawa Yoshinori、Nishikawa Hiroyoshi、Ando Yuichi、Takahashi Masahide、Enomoto Atsushi
- Journal Title
  
  Life Science Alliance
  
  Volume: 5 Issue: 6 Pages: e202101230-e202101230
- DOI
  10.26508/lsa.202101230
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K22807, KAKENHI-PROJECT-17H06162, KAKENHI-PROJECT-20H03528, KAKENHI-PROJECT-21K20821, KAKENHI-PROJECT-22K07000, KAKENHI-PROJECT-22H00455, KAKENHI-PROJECT-20H03467, KAKENHI-PROJECT-19K07503
[Journal Article] Detection of bacteria in blood circulation in patients receiving cancer chemotherapy2020
- Author(s)
  Akiko Ota, Sachi Morita, Ayumu Matsuoka, Tomoya Shimokata, Osamu Maeda, Ayako Mitsuma, Tetsuya Yagi, Takashi Asahara, Yuichi Ando
- Journal Title
  
  International Journal of Clinical Oncology
  
  Volume: 25 Issue: 1 Pages: 210-215
- DOI
  10.1007/s10147-019-01521-y
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K08950
[Journal Article] 3.抗がん薬の臨床薬理学～分子標的薬とその心毒性～2018
- Author(s)
  満間綾子、安藤雄一
- Journal Title
  
  医薬ジャーナル
  
  Volume: vol.54 No.12
- Data Source
  KAKENHI-PROJECT-16K08906
[Journal Article] リツキシマブ誘発性インフュージョンリアクションに関連する遺伝子多型の同定を目的としたファーマコゲノミクス研究2018
- Author(s)
  安藤泰樹, 莚田泰誠, 中村克徳
- Journal Title
  
  琉球医学会誌
  
  Volume: 37巻1-4号 Pages: 130-130
- Data Source
  KAKENHI-PROJECT-16K08374
[Journal Article] Muscle wasting associated with the long-term use of mTOR inhibitors.2016
- Author(s)
  Bishal Gyawali, Tomoya Shimokata, Kazunori Honda, Chihiro Kondoh, Naomi Hayashi, Yasushi Yoshino, Naoto Sassa, Yasuyuki Nakano, Momokazu Gotoh, Yuichi Ando.
- Journal Title
  
  Mol Clin Oncol.
  
  Volume: 5 Issue: 5 Pages: 641-646
- DOI
  10.3892/mco.2016.1015
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26460626
[Journal Article] Low skeletal muscle density is associated with poor survival in patients with metastatic gastric cancer receiving chemotherapy.2016
- Author(s)
  Nomi Hayashi, Yuichi Ando, Bishal Gyawali, Tomoya Shimokata, Osamu Maeda, Masahide Fukaya, Hidemi Goto, Masato Nagino and Yasuhiro Kodera.
- Journal Title
  
  Oncol Rep
  
  Volume: 35 Issue: 3 Pages: 1727-1231
- DOI
  10.3892/or.2015.4475
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-26460626
[Journal Article] Postoperatibe complications following neoadjuvant bevacizumab treatment for for advanced colorectal cancer2014
- Author(s)
  Yoshioka Y, Uehara K, Ebata T, Yokoyama Y, Mitsuma A, Ando Y, and Nagino M
- Journal Title
  
  Surg Today
  
  Volume: (in press) Issue: 7 Pages: 1300-1306
- DOI
  10.1007/s00595-013-0686-2
- Data Source
  KAKENHI-PROJECT-23590638
[Journal Article] Association between severe toxicity of nilotinib and UGT1A1 polymorphisms in Japanese patients with chronic myelogenous leukemia2013
- Author(s)
  Takashi Shibata, Yosuke Minami, Ayako Mitsuma, Sachi Morita, Megumi Inoue, Tomoya Shimokata, Mihoko Sugishita, Tomoyo Oguri, Tomoki Naoe, Yuichi Ando
- Journal Title
  
  International Journal of Clinical Oncology
  
  Volume: (in press) Issue: 2 Pages: 391-396
- DOI
  10.1007/s10147-013-0562-5
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590500, KAKENHI-PROJECT-25461412
[Journal Article] Genetic polymorphisms associated with oxaliplatin-induced peripheral neurotoxicity in Japanese patients with colorectal cancer2013
- Author(s)
  小栗知世、満間綾子、安藤雄一他
- Journal Title
  
  International Journal of Clinical Pharmacolgy and Therapeutics
  
  Volume: 51
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590500
[Journal Article] 特集:癌化学療法に伴う神経障害性疼痛-最近の研究動向臨床現場からの情報発信:「オキサリプラチンによる末梢神経障害の遺伝的背景」2013
- Author(s)
  満間綾子、安藤雄一
- Journal Title
  
  日本薬理学会誌
  
  Volume: vol.141 No.2 Pages: 62-65
- Data Source
  KAKENHI-PROJECT-22590500
[Journal Article] Genetic polymorphisms associated with oxaliplatin-induced peripheral neurotoxicity in Japanese patients with colorectal cancer2013
- Author(s)
  Tomoyo Oguri, Ayako Mitsuma, Megumi Inada-Inoue, Sachi Morita, Takashi Shibata, Tomoya Shimokata, Mihoko Sugishita, Goro Nakayama, Keisuke Uehara, Yoshinori Hasegawa, Yuichi Ando
- Journal Title
  
  Int J Clin Pharmacol Ther
  
  Volume: 51 Pages: 475-481
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590500
[Journal Article] As- sociation between bevacizumab relat- ed hypertension and VEGF gene poly- morphisms in Japanese patients with metastatic colorectal cancer2013
- Author(s)
  Morita S, Uehara K, Nakayama G, Inoue M, Mitsuma A, Shimokata T, Sugishita M, Shibata T, Oguri T, and Ando Y
- Journal Title
  
  Cancer Chemother Pharmacol
  
  Volume: 71 Issue: 2 Pages: 405-11
- DOI
  10.1007/s00280-012-2028-2
- Data Source
  KAKENHI-PROJECT-23590638
[Journal Article] 臨床現場からの情報発信　オキサリプラチンによる末梢神経障害の遺伝的背景2013
- Author(s)
  満間綾子、安藤雄一
- Journal Title
  
  日本薬理学会誌
  
  Volume: 141巻 Pages: 62-65
- NAID
  10031147608
- Data Source
  KAKENHI-PROJECT-22590500
[Journal Article] がん化学療法におけるpharmacogenomics研究の現状と問題点2012
- Author(s)
  満間綾子、安藤雄一
- Journal Title
  
  血液内科
  
  Volume: vol.64 No.1 Pages: 106-114
- NAID
  40019197402
- Data Source
  KAKENHI-PROJECT-22590500
[Journal Article] Prospective evaluation of corrected QT intervals and arrhythmias after exposure to epirubicin, cyclophosphamide, and 5-fluorouracil in women with breast cancer.2011
- Author(s)
  Koichi Kitagawa, Kenji Kawada, Ayako Mitsuma, Masataka Sawaki, Yuichi Ando, et al.
- Journal Title
  
  Ann Oncol in press
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590537
[Journal Article] 最新の治療:外来化学療法2011
- Author(s)
  安藤雄一
- Journal Title
  
  現代医学
  
  Volume: 59(2) Pages: 279-284
- NAID
  40019177434
- Data Source
  KAKENHI-PROJECT-22590500
[Journal Article] Prospective evaluation of pharmacokinetically guided dosing of carboplatin in Japanese patients with cancer2010
- Author(s)
  Shimokata T, Ando Y, Yasuda Y, Hamada A, Kawada K, Saito H, Matsuo S, Kondo M, Imaizumi K, Hasegawa Y
- Journal Title
  
  Cancer Sci
  
  Volume: 101 Pages: 2601-2605
- NAID
  10027834680
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590167
[Journal Article] Association between oxaliplatin-induced peripheral neuropathy and poly morphisms of the ERCC1 and GSTP1 genes.2010
- Author(s)
  稲田めぐみ, 満間綾子, 澤木正孝, 安藤雄一, 他
- Journal Title
  
  International Journal of Clinical Pharmacology and Therapeutice
  
  Volume: 48 Pages: 729-734
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590500
[Journal Article] The feasibility study of docetaxel in patients with anaplastic thyroid cancer.2010
- Author(s)
  河田健司, 満間綾子, 澤木正孝, 安藤雄一, 他
- Journal Title
  
  Japanese Journal of Clinical Oncology
  
  Volume: 40 Pages: 596-599
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590500
[Journal Article] 特集PK-PDとPGxの最前線「がん分子標的薬のPK-PDとPGx」2010
- Author(s)
  満間綾子、安藤雄一
- Journal Title
  
  月刊薬事
  
  Volume: vol.52 No.4 Pages: 39-46
- Data Source
  KAKENHI-PROJECT-22590500
[Journal Article] Associations between oxaliplatin-induced peripheral neuropathy and polymorphisms of the ERCC1 and GSTP1 genes.2010
- Author(s)
  Megumi Inada, Mitsuo Sato, Ayako Mitsuma, Masataka Sawaki, Yuichi Ando, et al.
- Journal Title
  
  Int J Clin Pharmacol Ther 48
  
  Pages: 729-734
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590537
[Journal Article] Prospective evaluation of pharmaco- kinetically guided dosing of carboplatin in Japanese patients with cancer.2010
- Author(s)
  Tomoya Shimokata, Yuichi Ando, et al.
- Journal Title
  
  Cancer Sci 101
  
  Pages: 2601-2605
- NAID
  10027834680
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590537
[Journal Article] Pharmacokinetic analysis of carboplatin in patients with cancer who are undergoing hemodialysis.2010
- Author(s)
  Tomoyo Oguri, Yuichi Ando, et al.
- Journal Title
  
  Cancer Chemother Pharmacol 66
  
  Pages: 813-817
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20590537
[Journal Article] Associations between oxaliplatin-induced peripheral neuropathy and polymorphisms of the ERCC1 and GSTP1 genes2010
- Author(s)
  Megumi Inada, Mitsuo Sato, Sachi Morita, Koichi Kitagawa, Kenji Kawada, Ayako Mitsuma, Masataka Sawaki, Ken-ichi Fujita, Yuichi Ando
- Journal Title
  
  Int J Clin Pharmacol Ther
  
  Volume: 48 Pages: 729-734
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590500
[Journal Article]2009
- Author(s)
  安藤雄一(執筆および編集)
- Journal Title
  
  外来がん化単療法マニュアル(文光堂)
- Data Source
  KAKENHI-PROJECT-20590537
[Journal Article] 副作用とその対策 ; 肝・腎・心毒性2009
- Author(s)
  佐藤光夫、安藤雄一
- Journal Title
  
  日本臨牀 67巻増刊
  
  Pages: 505-512
- Data Source
  KAKENHI-PROJECT-20590919
[Journal Article] Genetic linkage of UGT1A7 and UGT1A9 polymorphisms to UGT1A1^*6 is associated with reduced glucuronidase acitivity for SN-38 in Japanese patients with cancer.2007
- Author(s)
  Fujita K, Ando Y, Nagashima F, Yamamoto W, Eodo H, Araki K, Kodama K, Miya T, Narabayashi M, Sasaki Y
- Journal Title
  
  Cancer Chemother Pharmacol (in press)
- Data Source
  KAKENHI-PROJECT-16200038
[Journal Article] Novel single nucleotide polymorphism of UGT1A7 gene in Japanese.2006
- Author(s)
  Fujita K, Ando Y, Nagashima F, Yamamoto W, Eodo H, Araki K, Kodama K, Araki K, Miya T, Narabayashi M, Sasaki Y
- Journal Title
  
  Drug Metab Pharmacokinet. 21
  
  Pages: 75-8
- NAID
  10017318038
- Data Source
  KAKENHI-PROJECT-16200038
[Journal Article] Screening for adverse reactions to irinotecan treatment using the Invader? UGT1A12006
- Author(s)
  Hasegawa Y, Ando Y, Shimokata K.
- Journal Title
  
  Molecular Assay Expert Rev Mol Diagn 6
  
  Pages: 527-533
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-16200038
[Journal Article] Pharmacogenetic approach for cancer treatment-tailored medicine in practice.2006
- Author(s)
  Hasegawa Y, Ando Y, Ando M, Hashimoto N, Imaizumi K, Shimokata K
- Journal Title
  
  Ann N Y Acad. Sci. 1086
  
  Pages: 223-232
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16200038
[Journal Article] Pharmacogenetic impact of polymorphisms in the coding region of the UGT1A1 gene on SN-38 glucuronidation in Japanese patients with cancer.2006
- Author(s)
  Araki K, Fujita K, Ando Y, Nagashima F, Yamamoto W, Endou H, Miya T, Kodama K, Narabayashi M, Sasaki Y
- Journal Title
  
  Cancer Sci. 97
  
  Pages: 1255-1259
- NAID
  10019377373
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16200038
[Journal Article] Novel single nucleotide polymorphism of UGT1A9 gene in Japanese.2006
- Author(s)
  Fujita K, Ando Y, Nagashima F, Yamamoto W, Eodo H, Araki K, Kodama K, Araki K, Miya T, Narabayashi M, Sasaki Y
- Journal Title
  
  Drug Metab Pharmacokinet. 21
  
  Pages: 79-81
- NAID
  10017318060
- Data Source
  KAKENHI-PROJECT-16200038
[Journal Article] Pharmacogenetic approach for cancer treatment -- tailored medicine in practice.2006
- Author(s)
  Hasegawa Y, Ando Y, Ando M, Hashimoto N, Imaizumi K, Shimokata K.
- Journal Title
  
  Ann N Y Acad Sci 1086
  
  Pages: 223-232
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-16200038
[Journal Article] Novel single nucleotide polymorphism of UGT1A9 gene in Japanese.2006
- Author(s)
  Fujita K, Ando Y, Nagashima F, Yamamoto W, Endo H, Kodama K, Araki K, Miya T, Narabayashi M, Sasaki Y
- Journal Title
  
  Drug Metab Pharmacokinet. 21
  
  Pages: 79-81
- NAID
  10017318060
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16200038
[Journal Article] Novel single nucleotide polymorphism of UGT1A9 gene in Japanese.2006
- Author(s)
  Fujita K, Ando Y, Nagashima F, Yamamoto W, Endo H, Kodama K, Araki K, Miya T, Narabayashi M, Sasaki Y.
- Journal Title
  
  Drug Metab Pharmacokinet. 21
  
  Pages: 79-81
- NAID
  10017318060
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-16200038
[Journal Article] Pharmacogenetic impact of polymorphisms in the coding region of the UGT1A1 gene on SN-38 glucuronidation in Japanese patients with cancer.2006
- Author(s)
  Araki K, Fujita K, Ando Y, Nagashima F, Yamamoto W, Endou H, Miya T, Kodama K, Narabayashi M, Sasaki Y.
- Journal Title
  
  Cancer Sci 97
  
  Pages: 1255-9
- NAID
  10019377373
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-16200038
[Journal Article] Screening for adverse reactions to irinotecan treatment using the Invader?2006
- Author(s)
  Hasegawa Y, Ando Y, Shimokata K
- Journal Title
  
  UGT1A1 Molecular Assay Expert Rev Mol Diagn. 6
  
  Pages: 527-533
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16200038
[Journal Article] Novel single nucleotide polymorphism of UGT1A7 gene in Japanese.2006
- Author(s)
  Fujita K, Ando Y, Nagashima F, Yamamoto W, Endo H, Kodama K, Araki K, Miya T, Narabayashi M, Sasaki Y
- Journal Title
  
  Drug Metab Pharmacokinet. 21
  
  Pages: 75-78
- NAID
  10017318038
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16200038
[Journal Article] Pharmacogenetic approach for cancer treatment--tailored medicine in practice.2006
- Author(s)
  Hasegawa Y, Ando Y, Ando M, Hashimoto N, Imaizumi K, Shimokata K
- Journal Title
  
  Ann N Y Acad. Sci. 1086
  
  Pages: 223-232
- Data Source
  KAKENHI-PROJECT-16200038
[Journal Article] Novel single nucleotide polymorphism of UGT1A7 gene in Japanese.2006
- Author(s)
  Fujita K, Ando Y, Nagashima F, Yamamoto W, Endo H, Kodama K, Araki K, Miya T, Narabayashi M, Sasaki Y.
- Journal Title
  
  Drug Metab Pharmacokinet. 21
  
  Pages: 75-8
- NAID
  10017318038
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-16200038
[Journal Article] Pharmacogenetics of anticancer agents : UGT1A1 polymorphismand irinotecan toxicity2005
- Author(s)
  Yuichi Ando
- Journal Title
  
  Keio J Med 54
  
  Pages: 28-28
- Data Source
  KAKENHI-PROJECT-15790271
[Journal Article] Sequence effect of docetaxel and carboplatin on toxicity, tumor response and pharmacokinetics in non-small cell lung cancer patients : a phase I study of two sequences.2005
- Author(s)
  Maki Ando, Hideo Saka, Yuichi Ando, Hironobu Minami, Takafumi Kuzuya, Masashi Yamamoto, Atsushi Watanabe, Shuzo Sakai, Kaoru Shimokata, Yoshinori Hasegawa.
- Journal Title
  
  Cancer Chemother Pharmacol 55
  
  Pages: 552-558
- Data Source
  KAKENHI-PROJECT-16200038
[Journal Article] CellMLを基にした薬物動態モデリング2005
- Author(s)
  白潟宏之, 安藤雄一, 倉田正, 佐々木康綱, 小山博史
- Journal Title
  
  第6回日本医療情報学会学術大会論文誌 5(2)
  
  Pages: 24-26
- Data Source
  KAKENHI-PROJECT-16200038
[Journal Article] Gefitinib (Iressa) inhibits the CYP3A4-mediated formation of NPC, but activates that of APC from irinotecan.2005
- Author(s)
  Ken-ichi Fujita, Yuichi Ando, Masaru Narabayashi, Toshimichi Miya, Fumio Nagashima, Wataru Yamamoto, Keiji Kodama, Kazuhiro Araki, Hisashi Endo, Yasutsuna Sasaki.
- Journal Title
  
  Drug Metab Dispos 33
  
  Pages: 1785-1790
- Data Source
  KAKENHI-PROJECT-16200038
[Journal Article] Pharmacogenetics of irinotecan : a promoter polymorphism of UGT1A1 gene and severe adverse reactions to irinotecan.2005
- Author(s)
  Maki Ando, Yoshinori Hasegawa, Yuichi Ando.
- Journal Title
  
  Invest New Drugs 23
  
  Pages: 539-545
- Data Source
  KAKENHI-PROJECT-16200038
[Journal Article] 化学療法感受性とゲノム-(2)イリノテカン副作用2005
- Author(s)
  安藤雄一
- Journal Title
  
  ゲノム医学 5(2)
  
  Pages: 169-176
- Data Source
  KAKENHI-PROJECT-16200038
[Journal Article] Clinical pharmacogenetics of irinotecan (CPT-11).2005
- Author(s)
  Yuichi Ando, Yoshinori Hasegawa.
- Journal Title
  
  Drug Metab Rev 37
  
  Pages: 565-574
- Data Source
  KAKENHI-PROJECT-16200038
[Journal Article] Genetic polymorphism in the phenobarbital-responsive enhancer module of the UDP-glucuronosyltransferase (UGT) 1A1 gene and irinotecan toxicity.2005
- Author(s)
  Chiyoe Kitagawa, Maki Ando, Yuichi Ando, Yoshitaka Sekido, Kenji Wakai, Kazuyoshi Imaizumi, Kaoru Shimokata, Yoshinori Hasegawa.
- Journal Title
  
  Pharmacogenetics and Genomics 15
  
  Pages: 35-41
- Data Source
  KAKENHI-PROJECT-16200038
[Journal Article] グルクロン酸転移酵素UGT1A1の遺伝子多型に基づく塩酸イリノテカンの個別化治療.2005
- Author(s)
  安藤雄一
- Journal Title
  
  最新医学 60(9)
  
  Pages: 1870-1878
- Data Source
  KAKENHI-PROJECT-16200038
[Journal Article] 抗がん剤のファーマコジェノミクス2004
- Author(s)
  安藤雄一
- Journal Title
  
  血液・腫瘍科 48・2
  
  Pages: 162-166
- Data Source
  KAKENHI-PROJECT-15790271
[Journal Article] 薬理遺伝学からみた抗癌薬による白血球減少と下痢の予測2004
- Author(s)
  安藤雄一
- Journal Title
  
  臨床医薬 20・7
  
  Pages: 761-765
- NAID
  10012890849
- Data Source
  KAKENHI-PROJECT-15790271
[Journal Article] 抗がん剤のファーマコジェノミクス2004
- Author(s)
  安藤雄一, 佐々木康綱
- Journal Title
  
  血液・腫瘍科 48・2
  
  Pages: 162-166
- Data Source
  KAKENHI-PROJECT-16200038
[Journal Article] Clinical pharmacogenetics of irinotecan (CPT-11)2004
- Author(s)
  Yuichi Ando
- Journal Title
  
  Drug Metab Rev 36
  
  Pages: 16-16
- Data Source
  KAKENHI-PROJECT-15790271
[Journal Article] Genetic linkage of UGT1A7 and UGT1A9 polymorphisms to UGT1A1*6 is associated with reduced glucuronidase activity for SN-38 in Japanese patients with cancer.
- Author(s)
  Fujita K, Ando Y, Nagashima F, Yamamoto W, Eodo H, Araki K, Kodama K, Miya T, Narabayashi M, Sasaki Y.
- Journal Title
  
  Cancer Chemother Pharmacol (in press)
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-16200038
[Journal Article] Genetic linkage of UGT1A7 and UGT1A9 polymorphisms to UGT1A1^*6 is associated with reduced glucuronidase activity for SN-38 in Japanese patients with cancer.
- Author(s)
  Fujita K, Ando Y, Nagashima F, Yamamoto W, Eodo H, Araki K, Kodama K, Miya T, Narabayashi M, Sasaki Y
- Journal Title
  
  Cancer Chemother Pharmacol (in press)
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16200038
[Presentation] Significance of complement-expressing cancer-associated fibroblasts in tumor immunity2023
- Author(s)
  Yuki Miyai, Yuichi Ando, Atsushi Enomoto
- Organizer
  第20回日本臨床腫瘍学会学術集会（福岡国際会議場・マリンメッセ福岡）
- Data Source
  KAKENHI-PROJECT-20H03528
[Presentation] Longitudinal monitoring of cytotoxic drug exposure in an outpatient chemotherapy unit2023
- Author(s)
  Ayako Mitsuma, Minamishima Takuya, Maeda Osamu, Shimokata Tomoya, Takano Yuko, Furune Satoshi, Kondo Chiaki, Miyai Yuki, Yamada Satomi, Hara Mariko., Hama Masayo, Miyazaki Masayuki, Kataoka Tomomi, Sakai Yusuke, Yamada Kiyofumi, Ando Yuichi
- Organizer
  第20回日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-19K07083
[Presentation] 高齢がん患者における外来化学療法の現状2023
- Author(s)
  満間綾子、岡田咲樂、栁川まどか、池田義明、安藤雄一
- Organizer
  第34回　日本老年医学会　東海地方会
- Data Source
  KAKENHI-PROJECT-19K07083
[Presentation] Comparing Available Drug Information and Banned Substance Content in Kampo Medicines.2022
- Author(s)
  Jose Carlos Sandoval Tayag, Katsunori Nakamura et al.
- Organizer
  The 21st Asian Conference on Clinical Pharmacy (ACCP 2022 in Nagoya)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K07224
[Presentation] 5-fluorouracil と warfarin および降圧薬併用時の薬物相互作用.2022
- Author(s)
  潮平英郎, Jose Carlos Sandoval Tayag, 石井岳夫, 國場訓, 平田哲夫, 中村克徳
- Organizer
  第 43 回日本臨床薬理学会学術総会, 横浜, 2022 年 11 月 30 日～12 月 3 日, ポスター発表.
- Data Source
  KAKENHI-PROJECT-22K06743
[Presentation] 外来化学療法室における抗がん薬曝露モニタリングの観察研究2021
- Author(s)
  南島拓矢，満間綾子，前田修，下方智也，高野悠子，古根聡，山田里美，原万里子，濱昌代，宮崎雅之，片岡智美，藤野泰孝，安藤雄一，山田清文
- Organizer
  医療薬学フォーラム2021/第29回クリニカルファーマシーシンポジウム
- Data Source
  KAKENHI-PROJECT-19K07083
[Presentation] リツキシマブ投与によるインフュージョンリアクションとFCGRT遺伝子多型に関する研究2021
- Author(s)
  安藤泰樹、大関健志、莚田泰誠、木村和哲、飯田真介、満間綾子、安藤雄一、玉城啓太、益崎裕章、松永民秀、タヤグホセカルロス、潮平英郎、中村克徳
- Organizer
  医療薬学フォーラム2021／第29回クリニカルファーマシーシンポジウム
- Data Source
  KAKENHI-PROJECT-19K07224
[Presentation] Significance of meflin-positive cancer-associated fibroblasts in predicting response to immune checkpoint inhibitors in non-small cell lung cancer2020
- Author(s)
  Miyai Y, Enomoto A, Ando Y, Takahashi M
- Organizer
  2020 ASCO annual meeting Virtual Format (Poster)　Abstract ID: 3118(#182)　May 2020
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20H03528
[Presentation] リツキシマブ誘発性インフュージョンリアクションに関連する遺伝子多型の同定を目的としたファーマコゲノミクス研究2018
- Author(s)
  安藤泰樹, 莚田泰誠, 中村克徳
- Organizer
  琉球大学医学部　医科学研究発表会
- Data Source
  KAKENHI-PROJECT-16K08374
[Presentation] がん化学療法前後における血液中の細菌ribosomal RNA同定の臨床的意義2018
- Author(s)
  大田亜希子，横山幸浩，山田豪，八木哲也，菊森豊根，廣岡芳樹，吉川史隆，満間綾子，安藤雄一
- Organizer
  第16回日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-17K08950
[Presentation] がん化学療法前後における血液中の細菌リボソームRNA同定の臨床的意義2018
- Author(s)
  1.大田亜希子、松岡歩、水谷武史、下方智也、前田修、満間綾子、安藤雄一、八木哲也
- Organizer
  第51回制癌剤適応研究会
- Data Source
  KAKENHI-PROJECT-17K08950
[Presentation] 胃がん腹水中細胞を用いたCapeOX療法による遺伝子変化の解析2017
- Author(s)
  前田修、安藤雄一
- Organizer
  第50回制癌剤適応研究会
- Place of Presentation
  ホテルクレメント徳島（徳島県徳島市）
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26460936
[Presentation] 甲状腺未分化がんおよび低分化がんに対してレンバチニブを投与した3症例の使用経験2017
- Author(s)
  水谷武史、松岡歩、下方智也、前田修、満間綾子、安藤雄一、藤本保志
- Organizer
  第231回日本内科学会東海地方会
- Place of Presentation
  津市
- Data Source
  KAKENHI-PROJECT-16K08906
[Presentation] Temsirolimus induced muscle loss.2016
- Author(s)
  Bishal Gyawali, Tomoya Shimokata, Takefumi Mizutani, Osamu Maeda, Naoto Sassa, Yasushi Yoshino, Momokazu Gotoh, Yuichi Ando.
- Organizer
  The 2nd Asian Conference for Frailty and Sarcopenia
- Place of Presentation
  今池ガスビルホール（愛知県名古屋市）
- Year and Date
  2016-11-04
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26460626
[Presentation] Loss of muscle mass associated with the long term use of mTOR inhibitors.2016
- Author(s)
  Bishal Gyawali, Tomoya Shimokata, Kazunori Honda, Chihiro Kondoh, Naomi Hayashi, Yasushi Yoshino, Naoto Sassa, Yasuyuki Nakano, Momokazu Gotoh, Yuichi Ando
- Organizer
  第14回日本臨床腫瘍学会学術集会
- Place of Presentation
  神戸国際展示場・神戸国際会議場（兵庫県神戸市）
- Year and Date
  2016-07-28
- Data Source
  KAKENHI-PROJECT-26460626
[Presentation] Microarray analysis of gene expression in gastric cancer cells from ascitic fluids before and after capecitabine and oxaliplatin (CapeOX)2016
- Author(s)
  Osamu Maeda, Kazuhiro Ishiguro, Kohei Funasaka, Ryoji Miyahara, Yoshiki Hirooka, Hidemi Goto, Yuichi Ando
- Organizer
  2016 Gastrointestinal Cancers Symposium
- Place of Presentation
  サンフランシスコ　米国
- Year and Date
  2016-01-21
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26460936
[Presentation] 分子標的薬による治療を行った神経内分泌腫瘍6例の検討2016
- Author(s)
  大田亜希子、満間綾子、松岡　歩、水谷武史、下方智也、杉下美保子、前田　修、安藤雄一
- Organizer
  第229回日本内科学会東海地方会
- Place of Presentation
  浜松市
- Data Source
  KAKENHI-PROJECT-16K08906
[Presentation] 進行再発胃がん患者における筋肉量評価について2015
- Author(s)
  林直美、ビシャール・ギャワリ、下方智也、前田修、後藤秀実、梛野正人、小寺泰弘、安藤雄一．
- Organizer
  第48回制癌剤適応研究会
- Place of Presentation
  オークラアクトシティホテル浜松（浜松市）
- Year and Date
  2015-03-20
- Data Source
  KAKENHI-PROJECT-26460626
[Presentation] Relationship between diameter of retinal vessels and anti- tumor effect of bevacizumab contain- ing chemotherapy2013
- Author(s)
  満間綾子,伊藤逸毅,寺崎浩子,安藤雄一,他5名
- Organizer
  第11回日本臨床腫瘍学会学術集会
- Place of Presentation
  仙台国際センター(仙台市)
- Data Source
  KAKENHI-PROJECT-23590638
[Presentation] Relationship between diameter of retinal vessels and anti-tumor effect of bevacizumab-containing chemotherapy.2013
- Author(s)
  Ayako Mitsuma, Yasuki Ito, Tomoya Shimokata, Yuichiro Yoshioka, Chie Tanaka, Keisuke Uehara, Goro Nakayama, Hiroko Terasaki, Yuichi Ando.
- Organizer
  第11回日本臨床腫瘍学会学術集会
- Place of Presentation
  仙台国際センター（仙台市）
- Data Source
  KAKENHI-PROJECT-23590638
[Presentation] 多発性骨髄腫患者における新規抗がん薬の治療効果と眼底血管径との関連2012
- Author(s)
  満間綾子,伊藤逸毅,寺崎浩子,安藤雄一,他10名
- Organizer
  第50回日本癌治療学会学術集会
- Place of Presentation
  パシフィコ横浜(横浜市)
- Data Source
  KAKENHI-PROJECT-23590638
[Presentation] シンポジウム癌化学療法に伴う神経障害性疼痛-最近の研究動向「オキサリプラチンによる末梢神経障害の遺伝的背景」2012
- Author(s)
  安藤雄一
- Organizer
  第85回日本薬理学会年会
- Place of Presentation
  国立京都国際会館(京都府)
- Year and Date
  2012-03-16
- Data Source
  KAKENHI-PROJECT-22590500
[Presentation] ベバシズマブ投与大腸がん患者における眼底血管径の変化と臨床的効果の検討2012
- Author(s)
  満間綾子,伊藤逸毅,寺崎浩子,安藤雄一,他6名
- Organizer
  第71回日本癌学会学術総会
- Place of Presentation
  ロイトン札幌(札幌市)
- Year and Date
  2012-09-20
- Data Source
  KAKENHI-PROJECT-23590638
[Presentation] Peripheral neuropathy induced by oxaliplatin is associated with genetic polymorphisms2012
- Author(s)
  満間綾子、安藤雄一他
- Organizer
  22nd Meeting of the European Neurological Society
- Place of Presentation
  プラハ (チェコ共和国）
- Data Source
  KAKENHI-PROJECT-22590500
[Presentation] 進行大腸癌患者に対するオキサリプラチン治療による慢性末梢神経障害と薬理ゲノム学2012
- Author(s)
  小栗知世、満間綾子、安藤雄一他
- Organizer
  第71回日本癌学会学術総会
- Place of Presentation
  ロイトン札幌、札幌市教育文化会館、さっぽろ芸文館、札幌市民ホール（札幌市）
- Data Source
  KAKENHI-PROJECT-22590500
[Presentation] 転移再発大腸がん患者におけるベバシズマブ投与と眼底網膜血管径との関連2012
- Author(s)
  満間綾子,伊藤逸毅,寺崎浩子,安藤雄一,他7名
- Organizer
  第33回日本臨床薬理学会学術誌総会
- Place of Presentation
  沖縄コンベンションセンター(那覇市)
- Data Source
  KAKENHI-PROJECT-23590638
[Presentation] 進行大腸癌患者に対するオキサリプラチン治療による慢性末梢神経障害と薬理ゲノム学2012
- Author(s)
  小栗知世, 森田佐知, 柴田剛志, 井上めぐみ, 下方智也, 満間綾子, 安藤雄一
- Organizer
  第71回日本癌学会学術総会
- Place of Presentation
  札幌
- Data Source
  KAKENHI-PROJECT-22590500
[Presentation] Peripheral neuropathy induced by oxaliplatin is associated with genetic polymorphisms2012
- Author(s)
  Ayako Mitsuma, Tomoyo Oguri, Megumi Inada, Yuichi Ando
- Organizer
  22nd Meeting of the European Neurological Society
- Place of Presentation
  Prague, Czech Republic
- Data Source
  KAKENHI-PROJECT-22590500
[Presentation] オキサリプラチンによる末梢神経障害の遺伝的背景.癌化学療法に伴う神経障害性疼痛-最近の研究動向2012
- Author(s)
  安藤雄一
- Organizer
  第85回日本薬理学会年会
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-22590500
[Presentation] 慢性骨髄性白血病におけるニロチニブの副作用とUGT1A1遺伝子多型に関する研究2012
- Author(s)
  柴田剛志, 満間綾子, 南陽介, 森田佐知, 井上めぐみ, 小栗知世, 下方智也, 杉下美保子, 直江知樹, 安藤雄一
- Organizer
  第50回日本癌治療学会学術集会
- Place of Presentation
  横浜
- Data Source
  KAKENHI-PROJECT-22590500
[Presentation] 進行大腸がん患者におけるmFOLFOX6療法の有害事象と遺伝子多型の検討2011
- Author(s)
  満開綾子、稲田めぐみ、安藤雄一, 他
- Organizer
  第32回日本臨床薬理学会年会
- Place of Presentation
  アクトシティ浜松(静岡県)
- Year and Date
  2011-12-02
- Data Source
  KAKENHI-PROJECT-22590500
[Presentation] 外来化学療法における過敏症対策とその検証2011
- Author(s)
  幸本ゆき、安藤雄一, 他
- Organizer
  第49回日本癌治療学会
- Place of Presentation
  名古屋国際会議場(愛知県)
- Year and Date
  2011-10-28
- Data Source
  KAKENHI-PROJECT-22590500
[Presentation] 進行大腸がん患者におけるmFOLFOX6 療法の有害事象と遺伝子多型の検討2011
- Author(s)
  満間綾子, 稲田めぐみ, 柴田剛志, 森田佐知, 下方智也, 杉下美保子, 村崎由佳, 安藤雄一
- Organizer
  第32回日本臨床薬理学会年会
- Place of Presentation
  浜松
- Year and Date
  2011-12-01
- Data Source
  KAKENHI-PROJECT-22590500
[Presentation] The fruits of translational research and their application to clinical practice : genotype-based individualization of irinotecan chemotherapy.2010
- Author(s)
  Yuichi Ando
- Organizer
  第9回アジア臨床腫瘍学会
- Place of Presentation
  岐阜グランドホテル
- Year and Date
  2010-08-25
- Data Source
  KAKENHI-PROJECT-20590537
[Presentation] 塩酸イリノテカンのPK/PDとPGx研究の流れ.抗がん剤のPKIPDとPGx～個別化投薬に向けて～2010
- Author(s)
  安藤雄一
- Organizer
  第31回日本臨床薬理学会
- Place of Presentation
  京都国際会議場
- Year and Date
  2010-12-02
- Data Source
  KAKENHI-PROJECT-20590537
[Presentation] 塩酸イリノテカンのPK/PDとPGx研究の流れ抗がん剤のPK/PDとPGx～個別化投薬に向けて～2010
- Author(s)
  安藤雄一
- Organizer
  第31回日本臨床薬理学会
- Place of Presentation
  京都国際会議場
- Year and Date
  2010-12-02
- Data Source
  KAKENHI-PROJECT-20590537
[Presentation] The fruits of transla- tional research and their application to clinical practice : genotype- based individualization of irinotecan chemotherapy.2010
- Author(s)
  安藤雄一
- Organizer
  第9回アジア臨床腫瘍学会
- Place of Presentation
  岐阜グランドホテル
- Year and Date
  2010-08-25
- Data Source
  KAKENHI-PROJECT-20590537
[Presentation] 大学病院でのニーズに即した化学療法部の取り組み2010
- Author(s)
  満間綾子, 澤木正孝, 安藤雄一, 他
- Organizer
  第48回日本癌治療学会学術集会
- Place of Presentation
  京都市国立京都国際会館
- Year and Date
  2010-10-28
- Data Source
  KAKENHI-PROJECT-22590500
[Presentation] 多剤併用化学療法におけるQTc間隔延長と催不整脈作用の臨床的探索2009
- Author(s)
  喜多川浩一, 安藤雄一
- Organizer
  第47回日本癌治療学会総会
- Place of Presentation
  パシフィコ横浜(神奈川県)
- Data Source
  KAKENHI-PROJECT-20590537
[Presentation] 多剤併用化学療法におけるQTc間隔延長と催不整脈作用の臨床的探索2009
- Author(s)
  喜多川浩一, 安藤雄一, 他
- Organizer
  第47回日本癌治療学会総会
- Place of Presentation
  パシフィコ横浜
- Year and Date
  2009-10-24
- Data Source
  KAKENHI-PROJECT-20590537
[Presentation] 転移再発大腸がん患者におけるベバシズマブ投与と眼底網膜血管径との関連
- Author(s)
  満間綾子、伊藤逸毅、吉田啓子、三浦聖子、村崎由佳、下方智也、杉下美保子、上原圭介、中山吾郎、寺崎浩子、安藤雄一
- Organizer
  第33回日本臨床薬理学会学術誌総会
- Place of Presentation
  沖縄コンベンションセンター（那覇）
- Data Source
  KAKENHI-PROJECT-23590638
[Presentation] 多発性骨髄腫患者における新規抗がん薬の治療効果と眼底血管径との関連
- Author(s)
  満間綾子、伊藤逸毅、柴田剛志、小栗知世、森田佐知、井上めぐみ、下方智也、杉下美保子、村崎由佳、吉田啓子、富田章裕、直江知樹、寺崎浩子、安藤雄一
- Organizer
  第50回日本癌治療学会学術集会
- Place of Presentation
  パシフィコ横浜（横浜）
- Data Source
  KAKENHI-PROJECT-23590638
[Presentation] ベバシズマブ投与大腸がん患者における眼底血管径の変化と臨床的効果の検討
- Author(s)
  満間綾子、柴田剛志、小栗知世、森田佐知、井上めぐみ、下方智也、杉下美保子、安藤雄一
- Organizer
  第71回日本癌学会学術総会
- Place of Presentation
  ロイトン札幌（札幌）
- Data Source
  KAKENHI-PROJECT-23590638

1. MITSUMA Ayako (10467326)

# of Collaborated Projects: 10 results

# of Collaborated Products: 45 results
2. Shimokata Tomoya (70612745)

# of Collaborated Projects: 6 results

# of Collaborated Products: 11 results
3. NAKAMURA Katsunori (20361363)

# of Collaborated Projects: 4 results

# of Collaborated Products: 5 results
4. MATSUNAGA Tamihide (40209581)

# of Collaborated Projects: 4 results

# of Collaborated Products: 1 results
5. SAWAKI Masataka (20402597)

# of Collaborated Projects: 3 results

# of Collaborated Products: 6 results
6. Maeda Osamu (20378053)

# of Collaborated Projects: 3 results

# of Collaborated Products: 4 results
7. 益崎裕章 (00291899)

# of Collaborated Projects: 3 results

# of Collaborated Products: 1 results
8. SATO Mitsuo (70467281)

# of Collaborated Projects: 2 results

# of Collaborated Products: 2 results
9. KAWADA Kenji (30418743)

# of Collaborated Projects: 2 results

# of Collaborated Products: 1 results
10. SASAKI Ji-i (60419637)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
11. KAWAGUCHI Tatsuya (50244116)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
12. Urakawa Hiroshi (60584753)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
13. SASAKI Yasutsuna (20235279)

# of Collaborated Projects: 2 results

# of Collaborated Products: 15 results
14. 莚田泰誠 (40392146)

# of Collaborated Projects: 2 results

# of Collaborated Products: 1 results
15. HASEGAWA Yoshinori (20270986)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
16. HAMADA Akinobu (00322313)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
17. SAITO Hideyuki (40225727)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
18. ITO Yasuki (10313991)

# of Collaborated Projects: 1 results

# of Collaborated Products: 7 results
19. TERASAKI Hiroko (40207478)

# of Collaborated Projects: 1 results

# of Collaborated Products: 7 results
20. KIMURA Kazunori (00423848)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
21. Ohmori Shigeru (70169069)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
22. OYAMA Hiroshi (30194640)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
23. ONOGI Yuzo (90233593)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
24. KOIDE Daisuke (50313143)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
25. Fujita Ken-ichi (60281820)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
26. KATO Yukio (30251440)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
27. 後藤秀実 (10215501)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
28. 西田佳弘 (50332698)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
29. 筑紫聡 (90378109)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
30. 小澤英史 (60635572)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
31. 新井英介 (40612841)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
32. 生田国大 (40732657)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
33. 水谷武史 (60765519)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
34. 近藤豊 (00419897)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
35. 藤城光弘 (70396745)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
36. 古川和宏 (70624310)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
37. 榎本篤 (20432255)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
38. Iida Shinsuke

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
39. Mushiroda Taisei

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
40. 斎藤秀之

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
41. 宮井雄基

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Ando Yuichi 安藤 雄一

ANDO Yuichi 安藤 雄一

Research Projects

Research Products

Co-Researchers

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Mechanism of predicting the effects of immune checkpoint inhibitors based on the diversity of cancer-associated fibroblastsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Mechanism of diarrhea/enteritis caused by anticancer drugs and development of new treatmentPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Clinical significance of sarcopenia in cancer chemotherapyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Ando Yuichi 安藤雄一

ANDO Yuichi 安藤雄一

[Book] レジデントノート増刊　臨床現場の薬理学「がん薬物療法」2023